El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
Español (Latinoamérica)
Abbott Laboratories
Cerrado
SectorSalud
110.26 -0.16
Resumen
Variación precio
24h
Mínimo
108.68
Máximo
110.71
Ingresos | 132M 1.8B |
|---|---|
Ventas | 90M 11B |
P/B Media del Sector | 30.201 66.845 |
BPA | 1.5 |
Rentabilidad por dividendo | 2.19 |
Margen de beneficio | 15.499 |
Empleados | 115,000 |
EBITDA | -193M 2.8B |
Recomendaciones | Compra Fuerte |
|---|---|
Estimación a 12 meses | +24.53% upside |
Rentabilidad por dividendo Media del Sector | 2.19% 2.25% |
|---|---|
Próximas Ganancias | 15 abr 2026 |
Fecha Próximo Dividendo | 15 may 2026 |
Próxima Fecha de Ex Dividendo | 15 abr 2026 |
Capitalización de Mercado | -16B 196B |
|---|---|
Apertura anterior | 110.42 |
Cierre anterior | 110.26 |
Noticias sobre sentimiento de mercado
By Acuity
26%
74%
49 / 351 Clasificación en Healthcare
Puntuación técnica
By Trading Central
Confianza
Weak Bullish Evidence
Abbott Laboratories Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Abbott Laboratories Esperado
Precio Objetivo
By TipRanks
24.53% repunte
Estimación a 12 meses
Media 137.67 USD 24.53%
Máximo 158 USD
Mínimo 122 USD
De acuerdo con 16 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Abbott Laboratories Dist en los últimos 3 meses.
Sentimiento
By Acuity
49 / 351 Clasificación en Salud
Noticias sobre sentimiento de mercado
Coyuntura alcista
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por encima de la media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Live chat